← All organizations
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Government
Also known as: Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology | Federal Research Center for pediatric hematology, oncology and immunology | Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2008Last known activity
Jul 24, 2025
Timeline
1990s
- Jan 1, 1991
Federal Research Institute of Pediatric Hematology, Oncology and Immunology— Founded
Drugs by trial phase (51 distinct, 32 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Aplastic
- beta-Thalassemia
- Communicable Diseases
- Deficiency Diseases
- Graft vs Host Disease
- Granuloma
- Granuloma, Plasma Cell
- Granulomatous Disease, Chronic
- Hematologic Diseases
- Hepatoblastoma
- Histiocytosis
- Histiocytosis, Langerhans-Cell
- Hodgkin Disease
- Immunologic Deficiency Syndromes
- Infections
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Myelodysplastic Syndromes
- Nijmegen Breakage Syndrome
- Opportunistic Infections
- Pancytopenia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Sprains and Strains
- Syndrome
- Thalassemia
- Thrombocytopenia
- Wiskott-Aldrich Syndrome
Recent trials (37)
- NCT07232134Lead sponsorPhase 3Jul 24, 2025
- NCT07256210Lead sponsorPhase 2May 9, 2025
- NCT06756152Lead sponsorPhase 2/Phase 3Jul 10, 2024
- NCT06475820Lead sponsorPhase 2/Phase 3Dec 1, 2023
- NCT06198842Lead sponsorPhase 2Nov 22, 2023
- NCT06199427Lead sponsorPhase 2Nov 21, 2023
- NCT06071897Lead sponsorPhase 3Sep 1, 2023
- NCT05515029Lead sponsorPhase 3Aug 23, 2022
- NCT05549167Lead sponsorPhase 3May 30, 2022
- NCT05518383Lead sponsorPhase 4May 25, 2022
- NCT05346731Lead sponsorPhase 3Apr 1, 2022
- NCT04593368Lead sponsorPhase 2Dec 15, 2020
- NCT04499573Lead sponsorPhase 1/Phase 2Jul 27, 2020
- NCT04400045Lead sponsorPhase 2May 22, 2020
- NCT04723342Overall official - principal investigatorN/AFeb 1, 2020
Details
- Founded
- Moscow, RU Jan 1, 1991
- Last known activity
- Jul 24, 2025